International Journal of Infectious Diseases
Volume 14, Issue 7 , Pages e592-e595 , July 2010

Rotavirus disease burden, Nicaragua 2001–2005: defining the potential impact of a rotavirus vaccination program

  • Juan José Amador

      Affiliations

    • Program for Appropriate Technology in Health, Managua, Nicaragua
    • ,
  • Joshua Vasquez

      Affiliations

    • Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Atlanta, GA 30333, USA
    • ,
  • Maribel Orozco

      Affiliations

    • Ministerio de Salud, Managua, Nicaragua
    • ,
  • Cristina Pedreira

      Affiliations

    • PanAmerican Health Organization, Managua, Nicaragua
    • ,
  • Omar Malespin

      Affiliations

    • Ministerio de Salud, Managua, Nicaragua
    • ,
  • Lucia Helena De Oliveira

      Affiliations

    • PanAmerican Health Organization, Washington DC, USA
    • ,
  • Jacqueline Tate

      Affiliations

    • Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Atlanta, GA 30333, USA
    • ,
  • Umesh Parashar

      Affiliations

    • Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Atlanta, GA 30333, USA
    • ,
  • Manish Patel

      Affiliations

    • Centers for Disease Control and Prevention, 1600 Clifton Road, NE, Atlanta, GA 30333, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 404 639 2343; fax: +1 404 639 3607.

Received 28 May 2009 ,Revised 7 August 2009 ,Accepted 17 August 2009.

References 

  1. World Health Organization (WHO). Global and national estimates of deaths under age five attributable to rotavirus infection: 2004. Geneva: WHO; 2006. Available at: http://www.who.int/immunization_monitoring/burden/rotavirus_estimates/en/ (accessed November 2009).
  2. Parashar UD, Gibson CJ, Bresse JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis. 2006;12:304–306
  3. Glass RI, Parashar UD, Bresee JS, Turcios R, Fischer TK, Widdowson MA, et al. Rotavirus vaccines: current prospects and future challenges. Lancet. 2006;368:323–332
  4. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11–22
  5. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human–bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23–33
  6. Amador JJ, Vicari A, Turcios-Ruiz RM, Melendez DA, Malek M, Michel F, et al. Outbreak of rotavirus gastroenteritis with high mortality, Nicaragua, 2005. Rev Panam Salud Publica. 2008;23:277–284
  7. Patel M, Pedreira C, De Oliveira LH, et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA. 2009;301:2243–2251
  8. World Health Organization (WHO). Generic protocol for monitoring impact of rotavirus vaccination on rotavirus disease burden and viral strains. WHO/IVB/0816. Geneva: WHO; 2009, p. 1–73.
  9. United Nations Department of Economic and Social Affairs. World population prospects: the 2008 revision. United Nations; 2009. Available at: http://esa.un.org/unpp/index.asp (accessed November 2009).
  10. Figueroa Sarmiento M, Padilla N, Gutierrez H. Rotavirus en las diarreas infantiles de Honduras. Med Clín (Honduras). 1992;1:14–20
  11. Solorzano Giron JO, Molina IB, Turcios-Ruiz RM, Quiroz Mejia CE, Amendola LM, de Oliveira LH, et al. Burden of diarrhea among children in Honduras, 2000-2004: estimates of the role of rotavirus. Rev Panam Salud Publica. 2006;20:377–384
  12. Pan American Health Organization. Vigilancia de diarreas por rotavirus, 2005-2007. Available at: http://www.paho.org/Spanish/AD/FCH/IM/Rotavirus_TablasVigilanciaMarzo2008.pdf (accessed November 2009).
  13. Guardado JA, Clara WA, Turcios RM, Fuentes RA, Valencia D, Sandoval R, et al. Rotavirus in El Salvador: an outbreak, surveillance and estimates of disease burden, 2000–2002. Pediatr Infect Dis J. 2004;23:S156–S160
  14. Kane EM, Turcios RM, Arvay ML, Garcia S, Bresee JS, Glass RI. The epidemiology of rotavirus diarrhea in Latin America. Anticipating rotavirus vaccines. Rev Panam Salud Publica. 2004;16:371–377
  15. Velazquez FR, Garcia-Lozano H, Rodriguez E, Cervantes Y, Gomez A, Melo M, et al. Diarrhea morbidity and mortality in Mexican children: impact of rotavirus disease. Pediatr Infect Dis J. 2004;23:S149–S155
  16. Delayed onset and diminished magnitude of rotavirus activity—United States, November 2007–May 2008. MMWR Morb Mortal Wkly Rep 2008; 57:697–700.
  17. Tate JE, Panozzo CA, Payne DC, Patel MM, Cortese MM, Fowlkes AL, et al. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics. 2009;124:465–471
  18. World Health Organization. Vaccine Assessment and Monitoring Team. Generic protocols for (i) hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children and (ii) a community-based survey on utilization of health care services for gastroenteritis in children. Field test ed. Geneva: Vaccines and Biologicals, World Health Organization; 2002.

☆ The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention (CDC).

PII: S1201-9712(09)00349-X

doi: 10.1016/j.ijid.2009.08.014

International Journal of Infectious Diseases
Volume 14, Issue 7 , Pages e592-e595 , July 2010

Article Tools

* Image Usage & Resolution